Phytochemicals for Nutritional Use

Click ingredient brand name for product website.

Code Product Name Standardization Functional Activity
0301 Calebin A (1) New
CurCousin™
GRAS AFFIRMED
98% Calebin A Joint support
Liver health support
Metabolic health support
Weight management support
0336 Chrysin 97% Dihydroxyflavone Anti-inflammatory support
Cognitive health support
Sports nutrition
0522 Diindolylmethane (DIM) 98% DIM Antioxidant support
Bone health
0472 Forskolin Carbonate 98% Forskolin Carbonate Weight management support
0912 Indole-3-Carbinol 99.6% Indole-3-Carbinol Antioxidant support
Joint support
2100 Ipriflavone 98.5% Ipriflavone Bone health
1458 Oxyresveratrol (2)
OxyResvenox®
95% Oxyresveratrol Antioxidant support
Immune support
Support heart health
1819 Resveratrol (2)
Resvenox®
99% Resveratrol Antioxidant support
Immune support
Support heart health
2022 Tetrahydrocurcuminoids ODS
Curcumin C3 Reduct® ODS
95% Tetrahydrocurcuminoids Anti-inflammatory support
Antioxidant support
Oral health

SPATENTS

(1) Calebin A (CurCousin™ )

 US 8,933,121; US 9,328,330; AU2012366253; AU2014203122; CA2857543; JP6374716; KR10-1702702; NZ614076; NZ 715053; RU2543334; SG192695; ZA2013/05918; ZL201280012577.3: Anti-obesity potential of calebin A

 US 9,610,273; US 9,668,999; AU2014202312; CA2850999; CA2963383; EA027148; EP2937084; HK1210590; I-622384; JP6263707; KR10-1647549; NZ624269; MY-170067-A; PH1-2014-000244: Method for the treatment of hypercholesterolemia

 IDP000064827: Calebin A and its effect on hypercholesterolemia

 US 9,220,703; AU2014201769; CA2935898;EP2893926; JP6142446; KR10-1685263; KR10-1685333; MY-175867-A; NZ622909; PH1-2016-501138; SG11201605336Y: Composition and method for the protection of articular cartilage

 EA027614: Use of calebin A to protect mammalian articular cartilage from pathological damage

 US 9,365,486; AU2014203764; CA2858126; EA027726; EP2963007; HK1217689; JP6490927; KR10-1629561; NZ627247: Synthesis of calebin A and its biologically active analogs

 HK1210028: Calebin A for articular cartilage

 EP3085370: Calebin A for inducing lipolysis

 US 9,737,502; CA2893321; IDP000067993; JP6336943; KR10-1763474; MY-182000-A; PH1-2015-000188; RU2643297; SG10201503805X: Calebin A for hepatic steatosis

 US 9,539,232; CA2941050; RU2653103: Calebin A for osteoporosis

 EP2663185; HK1190874: Calebin A for use in the treatment of inflammation and obesity

(2) Oxyresvenox® / Resvenox®

 US 7,253,324: Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers

`

Disclaimer

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

    HEADQUARTERS

  • Sabinsa Corporation
    20 Lake Drive
    East Windsor
    NJ 08520, USA

  • +1 732 777 1111
  • +1 732 777 1443
  • info@sabinsa.com

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US